SP16

Serpin Pharma, LLC · Phase 1 active Small molecule

At a glance

Generic name	SP16
Sponsor	Serpin Pharma, LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

SP16 as a Therapeutic for COVID-19 Induced ARDS (PHASE1)
SP16 Inflammatory Response Inhibition Trial (PHASE1, PHASE2)
SP16 SERPIN-like Peptide Administration in Healthy Individuals (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SP16 CI brief — competitive landscape report
SP16 updates RSS · CI watch RSS
Serpin Pharma, LLC portfolio CI